Cytokinetics | CYTK - Ebitda



Cytokinetics reported $-153331000 in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
Acadia Pharmaceuticals USD 35.31M 13.07M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Cytokinetics USD -153331000 16.67M Mar/2025
Eisai JPY 8.81B 28.8B Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Exelixis USD 220.92M 26.71M Jun/2025
Geron USD -7550000 8.85M Jun/2025
Halozyme Therapeutics USD 225.5M 63.51M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Ligand Pharmaceuticals USD -40543000 50.88M Mar/2025
Merck USD 7.74B 625M Mar/2025
Novartis USD 6.17B 339M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025